Canadian Pharmaceuticals & Biotech Big Green Snowflakes

Medexus Pharmaceuticals

Market Cap: CA$95.5m

Operates as a pharmaceutical company in Canada and the United States.

Aurora Cannabis

Market Cap: CA$403.4m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

Rakovina Therapeutics

Market Cap: CA$7.0m

A biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets.

Green Thumb Industries

Market Cap: CA$1.7b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

1CM

Market Cap: CA$29.4m

Operates as a multi-jurisdictional cannabis company in Canada.

Decibel Cannabis

Market Cap: CA$37.5m

An integrated cannabis company, engages in the cannabis cultivation in Canada.

Oncolytics Biotech

Market Cap: CA$41.3m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments.

XORTX Therapeutics

Market Cap: CA$4.8m

A late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease.

BioSyent

Market Cap: CA$130.9m

Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.

Microbix Biosystems

Market Cap: CA$47.9m

A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.

Captor Capital

Market Cap: CA$1.7m

Engages in the retail sale of cannabis products in the United States.

Organigram Global

Market Cap: CA$242.3m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

Planet 13 Holdings

Market Cap: CA$96.0m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

Curaleaf Holdings

Market Cap: CA$863.4m

Produces and distributes cannabis products in the United States and internationally.

Sweet Earth Holdings

Market Cap: CA$6.7m

Does not have significant operations.

Innovotech

Market Cap: CA$13.7m

Provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally.

Algernon Pharmaceuticals

Market Cap: CA$2.2m

Operates as a clinical stage pharmaceutical development company in Canada and Australia.

Knight Therapeutics

Market Cap: CA$577.8m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

Bright Minds Biosciences

Market Cap: CA$271.8m

A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

Rubicon Organics

Market Cap: CA$28.8m

Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.

Covalon Technologies

Market Cap: CA$65.5m

Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.

NanoSphere Health Sciences

Market Cap: CA$359.6k

A nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada.

Satellos Bioscience

Market Cap: CA$105.8m

A biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia.

Cardiol Therapeutics

Market Cap: CA$148.4m

A clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.

BriaCell Therapeutics

Market Cap: CA$29.0m

A clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care.

Medicure

Market Cap: CA$11.1m

A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.

SOL Global Investments

Market Cap: CA$14.2m

A private equity firm specializing in growth capital to small and mid-sized businesses.

Cipher Pharmaceuticals

Market Cap: CA$317.0m

Operates as a specialty pharmaceutical company in Canada.

Cronos Group

Market Cap: CA$1.0b

A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

Medicenna Therapeutics

Market Cap: CA$78.4m

An immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases.

Sernova Biotherapeutics

Market Cap: CA$55.7m

Operates as a clinical-stage biotechnology company in Canada.

Grown Rogue International

Market Cap: CA$106.8m

A craft cannabis company, focuses on premium flower and flower-derived products.

Delivra Health Brands

Market Cap: CA$6.9m

Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide.

Auxly Cannabis Group

Market Cap: CA$105.4m

Operates as a consumer packaged goods company in the cannabis products market in Canada.

High Tide

Market Cap: CA$254.1m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Crescita Therapeutics

Market Cap: CA$10.0m

A dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally.